Lives are at stake and counterfeit N95 respirators make things worse for infection preventionists and others trying to care for COVID-19 patients. If you suspect that something being billed as an N95 is fake, report it to the CDC.
Charlatans rarely miss a chance to take advantage of a crisis, and that’s presently playing out amidst the COVID-19 pandemic. People are selling counterfeit N95 respirators, warns the US Centers for Disease Control and Prevention (CDC). The agency posted photos of dozens of counterfeit N95 masks on its website recently. You can tell at a glance that they’re counterfeit because the CDC helpfully draws a red slash through photos of the fakes. The real McCoys (which are not pictured on the site) are clearly marked as being approved by the National Institute for Occupational Safety and Health (NIOSH), the CDC says.
“Counterfeit respirators are products that are falsely marketed and sold as being NIOSH-approved and may not be capable of providing appropriate respiratory protection to workers,” the CDC warns. “When NIOSH becomes aware of counterfeit respirators or those misrepresenting NIOSH approval on the market, we will post them here to alert users, purchasers, and manufacturers.”
According to the CDC, here are the signs that a respirator might be counterfeit:
· No markings at all on the filtering facepiece respirator (FFR).
· No approval (TC) number on the FFR or headband.
· No NIOSH markings.
· NIOSH spelled incorrectly.
· Presence of decorative fabric or other decorative add-ons (e.g., sequins).
· Claims for the of approval for children (NIOSH does not approve any type of respiratory protection for children).
· Filtering facepiece respirator has ear loops instead of headbands.
Look for a NIOSH-approved label on the packaging or on the users’ instructions. Additionally, an abbreviated approval is affixed to the FFR itself. “NIOSH-approved FFRs will always have one the following designations: N95, N99, N100, R95, R99, R100, P95, P99, P100,” the CDC states. Verification of the product can be found on the NIOSH Certified Equipment List (CEL) or the NIOSH Trusted-Source.
The CDC is not the only one keeping an eye on just how N95s are being sold. Sometimes counterfeit peddlers of facemasks will attempt to piggyback on the makers of N95s that do meet NIOSH guidelines. For instance, 3M recently sued New Jersey-based Performance Supply LLC, accusing it of trying to sell 3M facemasks at 500% to 600% above 3M's marked prices to New York City officials; allegedly trying to profit at the epicenter of COVID-19 suffering, in other words.
The CDC warns that “Medicos is selling an N95 respirator using the Moldex approval number and label without Moldex’s permission. Medicos is not a NIOSH approval holder or private label holder.”
The CDC’s warnings are jargon free; they could be points being made by a friend. Examples:
· This product is not NIOSH-approved. Look at the markings on the front. The logo is wrong, there is no approval number.
· This product is not NOSH approved. No NIOSH logo or approval number on the face of the product.
And this warning is a particular favorite of the editors at Infection Control Today®.
“This is an example of a counterfeit N95 Respirator that was brought to NIOSH’s attention,” the CDC writes. “While the TC number and private label holder are valid, this unapproved unit can be identified by the misspelling of NIOSH on the front of the respirator.”
It’s spelled “NISH.”
And the point being made is crucial. Lives are at stake and counterfeit N95 respirators make things worse for infection preventionists and others trying to care for COVID-19 patients. If you suspect that something being billed as an N95 is fake, report it to the CDC.
Barrier Against Infection: Importance and Challenges of Isolation Room Cleaning in Hospitals
October 4th 2024Isolation rooms are essential for infection control in health care, relying on specialized design, advanced cleaning protocols, and technology to prevent cross-contamination and safeguard patient safety.
The Long-Term Care Chronicles: The Great Mitigators
August 27th 2024Enjoy this first installment of The Long-Term Care Chronicles With Robbie Hilliard, MSN, RN CIC, a column about managing special infection control situations in the long-term care patient population. This installment is about when 2 experts conflict about best care.
Urgent Need for a Paradigm Shift in Infectious Disease Control Amid 2024 Outbreaks
August 26th 2024The 2024 surge in infectious diseases like mpox, measles, and meningitis demands a paradigm shift in control strategies, emphasizing expanded expertise, improved airborne precautions, and rethinking cost-effectiveness in healthcare to prevent future outbreaks and protect public health.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.